Logo

American Heart Association

  2
  0


Final ID: 4143155

Sex-Specific Coronary Plaque Characteristics and Risk of Cardiovascular Events: Insights from the ISCHEMIA Trial

Abstract Body (Do not enter title and authors here): Background
Artificial-intelligence-enabled analysis of atherosclerotic plaque characteristics on coronary computed tomography angiography (CCTA) may improve sex-specific risk prediction of cardiovascular (CV) events.

Aims
The aim of this study was to examine sex differences in CCTA-derived atherosclerotic plaque analysis in ISCHEMIA participants, and to identify any interaction between sex and the prognostic value of quantitative atherosclerosis parameters in predicting CV events.

Methods
In a post-hoc analysis, atherosclerosis imaging quantitative CT (QCT) was performed on all available CCTA scans. Interaction analysis was performed to understand the impact of female sex on the relationship between QCT variables and the outcomes of CV death or myocardial infarction (MI), all-cause death, and MI alone over a median follow-up of 3.3 years.

Results
Of the 3645 participants with CCTA available for analysis, mean age was 64 and 21% were female. Females had lower total, calcified, non-calcified, and low-density non-calcified plaque volume than males (p<0.001 for all, Table). Percent atheroma volume (PAV=total plaque volume /vessel volume x 100%) was associated with CV death or MI in all participants, and the association was stronger in females (univariate HR: 2.37, 95% confidence interval (CI) 1.79, 3.14, p<0.001) than men (HR: 1.70, 95% CI 1.45, 2.00, p<0.001). There was a significant interaction showing accentuated risk of CV death or MI associated with greater PAV among females vs. males (HR for female*PAV: 1.42, 95% CI 1.03, 1.95, p=0.032, Figure), mainly driven by risk for MI.

Conclusions
In ISCHEMIA, females presenting with moderate or severe ischemia and obstructive CAD had less atherosclerotic plaque burden of all subtypes and less adverse plaque characteristics identified by CCTA than men. The risk associated with greater atherosclerotic burden (PAV) was higher among female participants than males for the composite outcome of CV death or MI.
  • Lakshmanan, Suvasini  ( University of Iowa , Coralville , Iowa , United States )
  • Boden, William  ( VA BOSTON HEALTHCARE SYSTEM , Boston , Massachusetts , United States )
  • Spertus, John  ( Saint Lukes Mid America Heart Inst , Kansas City , Missouri , United States )
  • Bangalore, Sripal  ( NYU Langone , New York , New York , United States )
  • Hochman, Judith  ( NYU SCHOOL OF MEDICINE , New York , New York , United States )
  • Reynolds, Harmony  ( NYU SCHOOL MEDICINE , New York , New York , United States )
  • Maron, David  ( STANFORD UNIVERSITY , Palo Alto , California , United States )
  • Wang, Yixin  ( Stanford Prevention Research Center , Stanford , California , United States )
  • Chen, Ying Qing  ( Stanford Prevention Research Center , Stanford , California , United States )
  • Mancini, G B John  ( University of British Columbia , West Vancouver , British Columbia , Canada )
  • Leipsic, Jonathon  ( University of British Columbia , West Vancouver , British Columbia , Canada )
  • Budoff, Matthew  ( LUNDQUIST INSTITUTE , Torrance , California , United States )
  • Hague, Cameron  ( University of British Columbia , West Vancouver , British Columbia , Canada )
  • Min, James  ( Cleerly, Inc. , Denver , New York , United States )
  • Stone, Gregg  ( Mount Sinai Medical Center , New York City , New York , United States )
  • Author Disclosures:
    Suvasini Lakshmanan: DO NOT have relevant financial relationships | William Boden: DO NOT have relevant financial relationships | John Spertus: DO have relevant financial relationships ; Consultant:Bristol Meyers Squibb:Active (exists now) ; Consultant:Edwards Healthscients:Past (completed) ; Consultant:Abbott:Past (completed) ; Consultant:Bayer:Past (completed) ; Consultant:Terrumo:Active (exists now) ; Royalties/Patent Beneficiary:Outcomes Instruments - Copyright to SAQ, KCCQ, and PAQ:Active (exists now) ; Consultant:Alnylam:Past (completed) ; Other (please indicate in the box next to the company name):Board of Directors for Blue Cross Blue Shield of Kansas City:Active (exists now) ; Research Funding (PI or named investigator):Janssen:Active (exists now) ; Consultant:Janssen:Active (exists now) ; Consultant:Sanofi Aventis:Past (completed) ; Consultant:Imbria Pharmaceuticals:Active (exists now) ; Consultant:Cytokinetics:Active (exists now) ; Research Funding (PI or named investigator):Bristol Meyers Squibb:Active (exists now) | Sripal Bangalore: DO have relevant financial relationships ; Advisor:Abbott Vascular:Active (exists now) ; Consultant:Shockwave:Active (exists now) ; Consultant:Recor:Active (exists now) ; Consultant:Pfizer:Active (exists now) ; Consultant:Amgen:Active (exists now) ; Consultant:Argon:Active (exists now) ; Consultant:Imperial Health:Active (exists now) ; Consultant:Inari:Active (exists now) ; Consultant:Biotronik:Active (exists now) ; Advisor:Boston Scientific:Active (exists now) | Judith Hochman: DO NOT have relevant financial relationships | Harmony Reynolds: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Abbott Vascular - in kind donation for research:Active (exists now) ; Consultant:HeartFlow:Active (exists now) ; Other (please indicate in the box next to the company name):Philips - in kind donation for research:Past (completed) ; Other (please indicate in the box next to the company name):SHL Telemedicine- in kind donation for research:Active (exists now) ; Other (please indicate in the box next to the company name):Siemens - in kind donation for research:Active (exists now) | David Maron: DO have relevant financial relationships ; Independent Contractor:Abiomed:Active (exists now) ; Consultant:Scilex:Past (completed) ; Consultant:Regeneron:Active (exists now) ; Researcher:Cleerly, Inc:Active (exists now) ; Individual Stocks/Stock Options:Ablative Solutions:Active (exists now) | Yixin Wang: No Answer | Ying Qing Chen: DO NOT have relevant financial relationships | G B John Mancini: DO NOT have relevant financial relationships | Jonathon Leipsic: No Answer | Matthew Budoff: DO have relevant financial relationships ; Researcher:General Electric:Active (exists now) | Cameron Hague: No Answer | James Min: DO have relevant financial relationships ; Employee:Cleerly, Inc.:Active (exists now) ; Advisor:Arineta:Active (exists now) ; Ownership Interest:Cleerly, Inc.:Active (exists now) | Gregg Stone: DO have relevant financial relationships ; Speaker:Medtronic:Past (completed) ; Consultant:HeartFlow:Active (exists now) ; Consultant:Therox:Active (exists now) ; Consultant:Valfix:Active (exists now) ; Consultant:Elucid:Past (completed) ; Consultant:Apollo Therapeutics:Past (completed) ; Consultant:Vectorious:Past (completed) ; Consultant:Miracor:Past (completed) ; Consultant:Robocath:Past (completed) ; Consultant:Ablative Solutions:Past (completed) ; Consultant:Daiichi Sankyo:Past (completed) ; Consultant:Abbott:Past (completed) ; Speaker:Boehringer Ingelheim:Past (completed) ; Speaker:Amgen:Past (completed) ; Speaker:Abiomed:Past (completed)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:
More abstracts on this topic:
A Case Series of Papillary Fibroelastomas on the Coumadin ridge

Aboukhatwa Omar, Akiki Elias, Kurmann Reto, Larson Kathryn, Keeney Michael, Bois Melanie, Klarich Kyle

A sex-specific CD4+ T cell response limits Coxsackievirus B pathogenesis in mice.

Robinson Christopher, Pattnaik Aryamav, Dhalech Adeeba, Condotta Stephanie, Corn Caleb, Richer Martin, Snell Laura

More abstracts from these authors:
Association of Serial Seattle Angina Questionnaire Assessments with Clinical Events in Chronic Coronary Disease: Insights from the ISCHEMIA Trial

O'keefe Evan, Hochman Judith, Spertus John, Jones Philip, Cho Yoon Joo, Saxon John, Boden William, Stone Gregg, Bangalore Sripal, Reynolds Harmony, Maron David

Sex Differences in Health Status Outcomes: Analysis of the ISCHEMIA Randomized Clinical Trial

Grodzinsky Anna, Maron David, Hochman Judith, Reynolds Harmony, Cho Yoon Joo, Jones Philip, Shaw Leslee, Bairey Merz C Noel, Boden William, Stone Gregg, Mark Daniel, Spertus John

You have to be authorized to contact abstract author. Please, Login
Not Available